November 2013 – J&J agrees to resolve federal investigations into the illegal marketing of Invega and Risperdal by paying over $2.2 billion.
November 2013 – J&J agrees to resolve federal investigations into the illegal marketing of Invega and Risperdal by paying over $2.2 billion.